Renal Cancer
Adjuvant treatment for resected renal cell carcinoma: Are all strategies equally negative? Potential implications for trial design with targeted agents - Abstract
September 12, 2013
Laparoendoscopic single-site radical nephrectomy for kidney tumor. Surgical technique, cosmetic and postoperative pain control outcomes - Abstract
September 12, 2013
Renal cell carcinoma in a horseshoe kidney: Radiology and pathology correlation - Abstract
September 12, 2013
Current management considerations for the incidentally detected small renal mass - Abstract
September 12, 2013
Influence of body mass index and smoking on the long-term survival of patients with renal cell cancer - Abstract
September 11, 2013
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies - Abstract
September 11, 2013
Inguinoscrotal hernia of the ureter combined with renal pelvic carcinoma - Abstract
September 9, 2013
First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma - Abstract
September 9, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN - Abstract
September 6, 2013
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies - Abstract
September 6, 2013
Prognostic role of pancreatic metastases from renal cell carcinoma: Results from an Italian center - Abstract
September 6, 2013
Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors - Abstract
September 5, 2013